SEC Form 4 · accession 0001606498-17-000044
AVANOS MEDICAL, INC. · AVNS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph Fralin Woody
Officer — Chief Executive Officer · Director
Period of report
Jun 26, 2017
Accepted (ET)
Jun 27, 2017 · 5:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001606498
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 26, 2017 | A | 25,044 | $0.00 | A | 25,044 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2 | $39.93 | Jun 26, 2017 | A | 149,053 | A | — | Jun 26, 2027 | Common Stock | 149,053 | 149,053 | D |
Explanation of responses
- F1Represents time-vested restricted stock units that vest 33.3% on June 26, 2018, 33.3% on June 26, 2019 and 33.4% on June 26, 2020, subject to earlier vesting in the event of death, disability or certain other events.
- F2The awards vest 30% on June 26, 2018, 30% on June 26, 2019, and 40% on June 26, 2020, subject to earlier vesting in the event of death, disability or certain other events.